Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: a post hoc analysis of the randomized FinnProstate Study VII-Reference-Cited by-同舟云学术

Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: a post hoc analysis of the randomized FinnProstate Study VII

Published:2014-03-31 Issue:6 Volume:48 Page:513-522
ISSN:2168-1805
Container-title:Scandinavian Journal of Urology
language:en
Short-container-title:Scandinavian Journal of Urology

Author:

Salonen Arto J.¹,Taari Kimmo²,Ala-Opas Martti³,Sankila Anna⁴,Viitanen Jouko⁵,Lundstedt Seppo⁶,Tammela Teuvo L. J.⁷,

Affiliation:

1. Department of Urology, Kuopio University Hospital, Kuopio, Finland

2. Department of Urology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

3. Department of Urology and

4. HUSLAB, Division of Pathology, Helsinki University Hospital, Helsinki, Finland

5. Department of Urology, Pohjois-Karjala Central Hospital, Joensuu, Finland

6. Department of Urology, Keski-Suomi Central Hospital, Jyväskylä, Finland

7. Department of Surgery, Tampere University Hospital, and School of Medicine, University of Tampere, Tampere, Finland

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.3109/21681805.2014.901410

Reference21 articles.

1. Finnish Multicenter Study Comparing Intermittent to Continuous Androgen Deprivation for Advanced Prostate Cancer: Interim Analysis of Prognostic Markers Affecting Initial Response to Androgen Deprivation

2. The FinnProstate Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

3. Advanced Prostate Cancer Treated with Intermittent or Continuous Androgen Deprivation in the Randomised FinnProstate Study VII: Quality of Life and Adverse Effects

5. The truly remarkable universality of half a standard deviation: confirmation through another look

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19);Journal of Clinical Oncology;2024-04-01

2. A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone–releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix);Indian Journal of Cancer;2022

3. Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update;Journal of Clinical Oncology;2021-04-10

4. Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer;Nature Reviews Urology;2020-06-30

5. Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations;Prostate Cancer and Prostatic Diseases;2018-08-21